Skip to content
Medical Health Aged Care, National News Current Affairs

ADA Tasmania backs strengthened vaping legislation in Tasmania

ADA Tasmania < 1 mins read

ADA Tasmania backs strengthened

Vaping Legislation in Tasmania

 

Statement by ADA Tasmania President Dr Katelyn McCracken

The Australian Dental Association Tasmania Branch commends the Tasmanian Government on its plans to introduce legislation continuing the requirement for all adults to have a doctor’s prescription to purchase vaping devices, and banning the purchase of these devices for all minors under 18.

Harmful substances have been found in e-cigarette liquids and the vapours produced, which could increase the risk of lung disease, heart disease and cancer. Initial research also suggests that vaping has adverse effects on the mouth, including fungal infections, dental caries, periodontal disease and oral injuries.

Furthermore, there is not sufficient evidence that e-cigarettes are an effective smoking cessation tool. In fact, people who take up the use of e-cigarettes are around three times more likely to take up smoking, and former smokers who use e-cigarettes are more likely to relapse.

The passing of this legislation by the Tasmanian Government will restrict the availability of vaping devices and ensure that use of these devices is guided by medical professionals, which gives them suitable opportunity to provide advice regarding smoking and vaping cessation.

The legislation will also reduce access to these devices for minors, reducing the chance of creating a new generation of people with nicotine addiction as well as reducing the future burden of the currently unknown long-term health impacts of vaping.

We are encouraged that Guy Barnett and the Tasmanian Government is listening to the advice of health professionals including dentists, to protect the public from the harms of e-cigarettes, and we call on all political parties to support this necessary reform.

For further information about vaping visit https://www.health.tas.gov.au/vaping.

For media inquiries, contact ADA Tasmania President

Dr Katelyn McCracken on 0459 716 146

Email: katelyn.mcc1@gmail.com

Media

More from this category

  • Disability, Medical Health Aged Care
  • 20/12/2024
  • 17:36
Kuremara

Kuremara to Open a State-of-the-Art Activity Center in Milton, QLD, in January 2025

Kuremara, a trusted and leading NDIS-registered provider in Australia, is excited to announce the opening of its newest facility—a cutting-edge activity center in Milton,…

  • Contains:
  • Legal, Medical Health Aged Care
  • 20/12/2024
  • 17:29
JGA Saddler

BREAKING NEWS: Australian law firm takes on Johnson & Johnson for selling Australians ineffective medicine

Vision available: Lawyer and doctor VNR, editorial photos and radio grabs included can be found in this SharePoint File In-person lawyer interviews available by…

  • Contains:
  • Medical Health Aged Care
  • 20/12/2024
  • 12:01
NDARC/UNSW

ADHD drug shows promise for treating methamphetamine dependence, landmark Australian study shows

A prescription medication used to treat attention deficit hyperactivity disorder (ADHD) could be repurposed as the first pharmacotherapy for people with methamphetamine dependence, according to a study published in Addiction. Results from the landmark ‘LiMA’ trial show that thepsychostimulant lisdexamfetamine can drastically reduce the need to use methamphetamine among those who are dependent on the illicit drug. Lead author and addiction medicine specialist Professor Nadine Ezard, who is Director of the National Centre for Clinical Research on Emerging Drugs (NCCRED), said the results were promising. "There is currently no pharmacotherapy approved for treating methamphetamine dependence," Professor Ezard said. “While further…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.